Nisa Investment Advisors LLC Boosts Position in Kenvue Inc. (NYSE:KVUE)

Nisa Investment Advisors LLC grew its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 151.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 573,797 shares of the company’s stock after purchasing an additional 345,199 shares during the period. Nisa Investment Advisors LLC’s holdings in Kenvue were worth $12,251,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in KVUE. Grove Bank & Trust grew its position in Kenvue by 438.4% in the fourth quarter. Grove Bank & Trust now owns 1,163 shares of the company’s stock valued at $25,000 after acquiring an additional 947 shares in the last quarter. Riverview Trust Co purchased a new position in shares of Kenvue in the third quarter valued at $30,000. Fortitude Family Office LLC grew its holdings in Kenvue by 106.6% during the 4th quarter. Fortitude Family Office LLC now owns 1,506 shares of the company’s stock valued at $32,000 after purchasing an additional 777 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in Kenvue during the 3rd quarter valued at $35,000. Finally, Versant Capital Management Inc increased its stake in Kenvue by 300.8% during the 4th quarter. Versant Capital Management Inc now owns 1,920 shares of the company’s stock worth $41,000 after buying an additional 1,441 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

KVUE has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft cut shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price objective for the company from $25.00 to $24.00 in a research report on Thursday, December 12th. Royal Bank of Canada upgraded Kenvue from a “hold” rating to a “moderate buy” rating in a research note on Monday, December 9th. UBS Group cut their target price on Kenvue from $24.00 to $23.00 and set a “neutral” rating on the stock in a research report on Thursday, January 16th. Barclays reduced their target price on Kenvue from $23.00 to $21.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Finally, Piper Sandler upgraded shares of Kenvue from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $21.00 to $26.00 in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Kenvue currently has a consensus rating of “Hold” and an average price target of $23.08.

Kenvue Stock Down 0.0 %

Shares of NYSE:KVUE opened at $20.75 on Friday. The company’s fifty day moving average is $22.26 and its two-hundred day moving average is $21.74. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.46. The stock has a market capitalization of $39.77 billion, a price-to-earnings ratio of 37.72, a price-to-earnings-growth ratio of 2.00 and a beta of 1.46.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The business had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same quarter in the prior year, the firm earned $0.31 EPS. The company’s revenue for the quarter was down .4% compared to the same quarter last year. Equities analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be issued a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.95%. The ex-dividend date of this dividend is Wednesday, February 12th. Kenvue’s dividend payout ratio (DPR) is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.